Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT05051059
Recruiting
Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients
Not applicable · Belgium · 1 site
Registry update: 16 Mar 2026
NCT05039801
Recruiting
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
Phase 1 · United States · 1 site
Registry update: 6 Oct 2026
NCT04941274
Recruiting
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
Phase 1/2 · United States · 1 site
Registry update: 16 Oct 2026
NCT04305548
Recruiting
Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Phase 2 · Italy · 7 sites
Registry update: 27 Mar 2026
NCT04535271
Recruiting
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
Phase 2 · United States · 1 site
Registry update: 24 Feb 2025
NCT05961761
Recruiting
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Phase 2 · Denmark, Norway, Sweden · 4 sites
Registry update: 27 Jul 2023
NCT04890067
Recruiting
Observational Study in Localized Osteosarcoma
Not applicable · Italy · 16 sites
Registry update: 3 Nov 2026
NCT04698785
Recruiting
Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients
Phase 2 · France · 16 sites
Registry update: 17 Feb 2026
NCT05231655
Recruiting
Ex VIvo DEtermiNed Cancer Therapy
Not applicable · United Kingdom · 1 site
Registry update: 24 Feb 2025
NCT04498767
Recruiting
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Not applicable · Belgium, Switzerland, Germany, France, United Kingdom, Italy, Poland · 13 sites
Registry update: 26 Aug 2024
NCT04901702
Recruiting
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/2 · Canada, United States · 10 sites
Registry update: 19 May 2026
NCT04757337
Recruiting
Comparison of Cyclophosphamide and doxorubicin as a first line treatment in elderly patients with metastatic sarcoma
Phase 3 · France · 19 sites
Registry update: 26 Apr 2024
NCT04845893
Recruiting
Observational Study on Skeletal Ewing's Sarcoma
Not applicable · Italy · 18 sites
Registry update: 2 Jan 2026
NCT04999761
Recruiting
AB122 Platform Study
Phase 1 · Japan · 9 sites
Registry update: 5 Aug 2026
NCT04785196
Recruiting
APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors
Phase 1/2 · China · 3 sites
Registry update: 26 Feb 2025
NCT04921917
Recruiting
Exercise and Soft Tissue Sarcoma
Not applicable · United States · 1 site
Registry update: 8 Apr 2026
NCT04872543
Recruiting
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
Phase 2 · United States · 7 sites
Registry update: 5 Feb 2026
NCT04776525
Recruiting
Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma
Phase 2 · Norway · 2 sites
Registry update: 21 Oct 2026
NCT03967834
Recruiting
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Not applicable · France · 20 sites
Registry update: 10 Feb 2026
NCT04079179
Recruiting
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Phase 2 · United States · 12 sites
Registry update: 26 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.